首页 > 最新文献

Head & Neck Pathology最新文献

英文 中文
Cemento-Osseous Dysplasia in a Female Bronze Age Skeleton (North Caucasus). 北高加索一具青铜时代女性骨骼骨水泥-骨发育不良。
IF 4.1 Q2 PATHOLOGY Pub Date : 2025-02-25 DOI: 10.1007/s12105-025-01767-1
Julia Gresky, Melina Frotscher, Sophia Thiem, Alexander Stoessel, Alexey Kalmykov, Natalia Berezina

Purpose: The earliest known case of cemento-osseous dysplasia could be detected in a Bronze Age skeleton, dating back 4500 years ago in the region of the North Caucasus. Although the soft tissue was missing, sufficient diagnosis could be achieved by using different methods that prove the existence of fibro-osseous processes already in prehistory. Skeletal remains provide a direct view of such changes which cannot be obtained from a living patient without compromising.

Methods: A skeleton of a 30-40-year-old female individual from the burial mound of Budyonnovsk 10 (including 19 individuals) in Southern Russia was investigated using macroscopic, radiographic, and microscopic methods.

Results: In the mandible, destruction of the labial wall of the alveoli 32 and 31 is already visible macroscopically. At the base of the lesion, the original bone is replaced by fine porous bone including small dense particles: plain radiography and computed tomography evidence localized processes to the periapical areas of all lower incisors. The lesions are mainly radiolucent, only the particles in alveolus 32 have a radiopaque appearance. Microscopy shows woven bone as filling of the lesions and additional hypocellular materials in alveolus 32, which can best be explained as cementum-like structures.

Conclusions: The lesion´s location in the periapical areas of the lower incisors, the woven bone, and cementum-like structures fit the diagnosis of periapical cemento-osseous dysplasia. The presence of a second individual with focal cemento-osseous dysplasia in this burial mound is an interesting co-occurrence that requires further genetic analysis.

Limitations: The diagnosis is solely based on the skeletal remains, soft tissue components are missing.

Suggestions for further research: Genetic analyses are planned to detect the underlying mutation for the two individuals.

目的:已知最早的骨水泥发育不良病例可以在一具青铜时代的骨骼中发现,该骨骼可追溯到4500年前的北高加索地区。虽然软组织缺失,但通过使用不同的方法可以获得充分的诊断,证明在史前已经存在纤维骨过程。骨骼遗骸提供了对这些变化的直接观察,而这些变化是不可能在不妥协的情况下从活着的病人身上获得的。方法:采用宏观、射线摄影和显微方法研究了俄罗斯南部Budyonnovsk 10(包括19个个体)墓地中一具30-40岁女性个体的骨骼。结果:在下颌骨,牙槽32和31唇壁的破坏已经可见。在病变的底部,原始骨被包括小致密颗粒的细多孔骨所取代:x线平片和计算机断层扫描表明,所有下门牙的根尖周区域都有局部病变。病灶以透光为主,只有肺泡32内的颗粒不透光。显微镜下可见编织骨充盈病变,肺泡内有细胞减少物质32,最好解释为骨质样结构。结论:病变位于下切牙根尖周区、编织骨和骨质样结构符合根尖周骨质发育不良的诊断。第二例局灶性骨水泥发育不良患者的出现是一种有趣的共生现象,需要进一步的遗传分析。局限性:诊断仅基于骨骼残骸,软组织成分缺失。对进一步研究的建议:计划进行基因分析,以检测两个人的潜在突变。
{"title":"Cemento-Osseous Dysplasia in a Female Bronze Age Skeleton (North Caucasus).","authors":"Julia Gresky, Melina Frotscher, Sophia Thiem, Alexander Stoessel, Alexey Kalmykov, Natalia Berezina","doi":"10.1007/s12105-025-01767-1","DOIUrl":"10.1007/s12105-025-01767-1","url":null,"abstract":"<p><strong>Purpose: </strong>The earliest known case of cemento-osseous dysplasia could be detected in a Bronze Age skeleton, dating back 4500 years ago in the region of the North Caucasus. Although the soft tissue was missing, sufficient diagnosis could be achieved by using different methods that prove the existence of fibro-osseous processes already in prehistory. Skeletal remains provide a direct view of such changes which cannot be obtained from a living patient without compromising.</p><p><strong>Methods: </strong>A skeleton of a 30-40-year-old female individual from the burial mound of Budyonnovsk 10 (including 19 individuals) in Southern Russia was investigated using macroscopic, radiographic, and microscopic methods.</p><p><strong>Results: </strong>In the mandible, destruction of the labial wall of the alveoli 32 and 31 is already visible macroscopically. At the base of the lesion, the original bone is replaced by fine porous bone including small dense particles: plain radiography and computed tomography evidence localized processes to the periapical areas of all lower incisors. The lesions are mainly radiolucent, only the particles in alveolus 32 have a radiopaque appearance. Microscopy shows woven bone as filling of the lesions and additional hypocellular materials in alveolus 32, which can best be explained as cementum-like structures.</p><p><strong>Conclusions: </strong>The lesion´s location in the periapical areas of the lower incisors, the woven bone, and cementum-like structures fit the diagnosis of periapical cemento-osseous dysplasia. The presence of a second individual with focal cemento-osseous dysplasia in this burial mound is an interesting co-occurrence that requires further genetic analysis.</p><p><strong>Limitations: </strong>The diagnosis is solely based on the skeletal remains, soft tissue components are missing.</p><p><strong>Suggestions for further research: </strong>Genetic analyses are planned to detect the underlying mutation for the two individuals.</p>","PeriodicalId":47972,"journal":{"name":"Head & Neck Pathology","volume":"19 1","pages":"28"},"PeriodicalIF":4.1,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11861816/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143494252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reevaluating Histopathologic and Molecular Insights in Ameloblastoma Management: A Call for Methodological Refinement. 重新评估成釉细胞瘤管理的组织病理学和分子见解:对方法改进的呼吁。
IF 4.1 Q2 PATHOLOGY Pub Date : 2025-02-19 DOI: 10.1007/s12105-025-01764-4
Carlos M Ardila, Pradeep K Yadalam
{"title":"Reevaluating Histopathologic and Molecular Insights in Ameloblastoma Management: A Call for Methodological Refinement.","authors":"Carlos M Ardila, Pradeep K Yadalam","doi":"10.1007/s12105-025-01764-4","DOIUrl":"10.1007/s12105-025-01764-4","url":null,"abstract":"","PeriodicalId":47972,"journal":{"name":"Head & Neck Pathology","volume":"19 1","pages":"23"},"PeriodicalIF":4.1,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11839546/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinicopathological and Immunohistochemical Risk Predictors for Ameloblastoma Recurrence. 成釉细胞瘤复发的临床病理和免疫组织化学风险预测因素。
IF 4.1 Q2 PATHOLOGY Pub Date : 2025-02-17 DOI: 10.1007/s12105-024-01743-1
Hévila de Figueiredo Pires, Glória Maria de França, Hannah Gil de Farias Morais, Weslay Rodrigues da Silva, Roseana de Almeida Freitas, Hébel Cavalcanti Galvão

Purpose: Measure associations between clinicopathological and immunohistochemical human Mut-L homologue 1 (hMLH1) gene, and human Mut-L homologue 2 (hMSH2) genes, variables in recurrent AMBs.

Methods: This study consisted of a research retrospective, observational case-control study consisting of 22 cases of recurrent AMB and 22 non-recurrent cases. Cases of AMB with more than one year of follow-up were included in the study. Quantitative immunohistochemical analysis was performed considering the cellular location (nuclear) of the proteins studied. The McNemar test was used to compare variables between primary and recurrent AMBs. Recurrence-free survival was analyzed by the Kaplan-Meier method and survival functions were compared according to the variables using the log-rank test.

Results: The posterior mandible was the most affected site in the recurrent (n = 18, 81.8%) and non-recurrent groups (n = 16, 72.8%). Recurrence-free survival was 50.0 (34.5-63.6) months. The following factors were significantly associated with AMB recurrence: presence of cortical bone expansion (p = 0.01), absence of bone reconstruction (p = 0.02), conservative treatment (p = 0.02), loss of hMSH2 (p = 0.01) and hMLH1 (p = 0.04) immunoexpression, and strong Ki-67 immunoexpression (p = 0.03). The risk factors for AMB recurrence were anatomical location (OR = 3.31), locularity (OR = 1.07), cortical expansion (OR = 6.17), cortical perforation (OR = 2.10), bone resorption (OR = 1.52), tooth impaction (OR = 1.86), jaw reconstruction (OR = 6.92), and immunoexpression of hMSH2 (OR = 10.0) and hMLH1 (OR = 4.50).

Conclusion: Radiographic appearance, treatment modality, and immunoexpression of mismatch repair proteins can be used as predictors of AMB recurrence.

目的:测量临床病理和免疫组织化学人类Mut-L同源物1 (hMLH1)基因和人类Mut-L同源物2 (hMSH2)基因之间的关系,这些基因是复发性AMBs的变量。方法:本研究采用回顾性、观察性病例对照研究,包括22例复发性AMB和22例非复发性AMB。随访超过一年的AMB病例被纳入研究。考虑到所研究蛋白的细胞位置(核),进行定量免疫组织化学分析。McNemar试验用于比较原发性和复发性AMBs之间的变量。采用Kaplan-Meier法分析无复发生存率,采用log-rank检验比较各变量的生存函数。结果:复发组(n = 18, 81.8%)和非复发组(n = 16, 72.8%)中,后颌骨是受影响最大的部位。无复发生存期为50.0(34.5-63.6)个月。与AMB复发相关的因素有:皮质骨扩张(p = 0.01)、骨重建缺失(p = 0.02)、保守治疗(p = 0.02)、hMSH2 (p = 0.01)、hMLH1 (p = 0.04)免疫表达缺失、Ki-67强免疫表达(p = 0.03)。AMB复发的危险因素为解剖位置(OR = 3.31)、局限性(OR = 1.07)、皮质扩张(OR = 6.17)、皮质穿孔(OR = 2.10)、骨吸收(OR = 1.52)、牙嵌塞(OR = 1.86)、颌骨重建(OR = 6.92)、hMSH2 (OR = 10.0)和hMLH1 (OR = 4.50)的免疫表达。结论:影像学表现、治疗方式和错配修复蛋白的免疫表达可作为AMB复发的预测因素。
{"title":"Clinicopathological and Immunohistochemical Risk Predictors for Ameloblastoma Recurrence.","authors":"Hévila de Figueiredo Pires, Glória Maria de França, Hannah Gil de Farias Morais, Weslay Rodrigues da Silva, Roseana de Almeida Freitas, Hébel Cavalcanti Galvão","doi":"10.1007/s12105-024-01743-1","DOIUrl":"10.1007/s12105-024-01743-1","url":null,"abstract":"<p><strong>Purpose: </strong>Measure associations between clinicopathological and immunohistochemical human Mut-L homologue 1 (hMLH1) gene, and human Mut-L homologue 2 (hMSH2) genes, variables in recurrent AMBs.</p><p><strong>Methods: </strong>This study consisted of a research retrospective, observational case-control study consisting of 22 cases of recurrent AMB and 22 non-recurrent cases. Cases of AMB with more than one year of follow-up were included in the study. Quantitative immunohistochemical analysis was performed considering the cellular location (nuclear) of the proteins studied. The McNemar test was used to compare variables between primary and recurrent AMBs. Recurrence-free survival was analyzed by the Kaplan-Meier method and survival functions were compared according to the variables using the log-rank test.</p><p><strong>Results: </strong>The posterior mandible was the most affected site in the recurrent (n = 18, 81.8%) and non-recurrent groups (n = 16, 72.8%). Recurrence-free survival was 50.0 (34.5-63.6) months. The following factors were significantly associated with AMB recurrence: presence of cortical bone expansion (p = 0.01), absence of bone reconstruction (p = 0.02), conservative treatment (p = 0.02), loss of hMSH2 (p = 0.01) and hMLH1 (p = 0.04) immunoexpression, and strong Ki-67 immunoexpression (p = 0.03). The risk factors for AMB recurrence were anatomical location (OR = 3.31), locularity (OR = 1.07), cortical expansion (OR = 6.17), cortical perforation (OR = 2.10), bone resorption (OR = 1.52), tooth impaction (OR = 1.86), jaw reconstruction (OR = 6.92), and immunoexpression of hMSH2 (OR = 10.0) and hMLH1 (OR = 4.50).</p><p><strong>Conclusion: </strong>Radiographic appearance, treatment modality, and immunoexpression of mismatch repair proteins can be used as predictors of AMB recurrence.</p>","PeriodicalId":47972,"journal":{"name":"Head & Neck Pathology","volume":"19 1","pages":"22"},"PeriodicalIF":4.1,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11832845/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143442248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
International Consensus Recommendations of Diagnostic Criteria and Terminologies for Extranodal Extension in Head and Neck Squamous Cell Carcinoma: An HN CLEAR Initiative (Update 1). 头颈部鳞状细胞癌结外延伸诊断标准和术语的国际共识建议:一项HN CLEAR倡议(更新1)。
IF 4.1 Q2 PATHOLOGY Pub Date : 2025-02-07 DOI: 10.1007/s12105-025-01753-7
Ruta Gupta, Timothy Fielder, Munita Bal, Simion I Chiosea, Jane E Dahlstrom, Aanchal Kakkar, Katalin Kiss, Jan Laco, Neha Mittal, Sunil Pasricha, Spinder Samra, Nina Zidar, Martin Bullock, Rebecca Chernock, William Faquin, Shao Hui Huang, Jean Yang, Sun Och Yoon

Purpose: Extranodal extension (ENE) increases the risk of recurrence and death in head and neck squamous cell carcinoma (HNSCC) patients and is an indication for treatment escalation. Histopathology forms the mainstay of diagnosing ENE. There is substantial variation in the diagnosis of ENE and related terminology. Harmonising the diagnostic criteria for ENE was identified as a priority by the Head and Neck Consensus Language for Ease of Reproducibility (HN CLEAR) Steering Committee and its global stakeholders.

Methods: An international working group including 16 head and neck pathologists from eight countries across five continents evaluated whole slide images of haematoxylin and eosin-stained sections depicting potential diagnostic problems through nine virtual meetings to develop consensus guidelines.

Results: ENE should be diagnosed only when viable carcinoma extends through the primary lymph node (LN) capsule and directly interacts with the extranodal host environment with or without desmoplastic stromal response. Identifying the original LN capsule and reconstruction of its contour can assist in the detection and assessment of ENE. The term matting is recommended for confluence of two or more nodes due to histologically identifiable tumour extending from one LN to another. Matting constitutes major form of ENE. On the other hand, the terms fusion/adhesion/confluence/conglomeration and other synonyms of adhesion should be limited to confluence due to fibrosis or inflammation without histologically identifiable tumour between involved lymph nodes. Tumour extension along narrow needle tracks or spillage of cyst contents following an FNA do not constitute ENE.

Conclusions: The consensus recommendations encompassing the definition of ENE, macroscopic and histologic examination of lymph nodes (LN) and practical guidelines for handling challenging cases are provided.

目的:结外延伸(ENE)增加头颈部鳞状细胞癌(HNSCC)患者复发和死亡的风险,是治疗升级的指征。组织病理学是诊断ENE的主要方法。ENE的诊断和相关术语有很大的差异。协调ENE的诊断标准被头颈部易重复性共识语言(HN CLEAR)指导委员会及其全球利益相关者确定为优先事项。方法:由来自五大洲八个国家的16名头颈部病理学家组成的国际工作组通过9次虚拟会议评估了血红素和伊红染色切片的全切片图像,描绘了潜在的诊断问题,以制定共识指南。结果:只有当活的癌通过原发性淋巴结(LN)囊扩展,并与结外宿主环境直接相互作用,伴有或不伴有结缔组织增生间质反应时,才应诊断为ENE。识别LN囊原并重建其轮廓有助于ENE的检测和评估。由于组织学上可识别的肿瘤从一个淋巴结延伸到另一个淋巴结而导致两个或多个淋巴结汇合时,推荐使用术语matting。抠图是ENE的主要形式。另一方面,术语融合/粘附/融合/聚集和其他粘附的同义词应限于受累淋巴结之间由于纤维化或炎症而没有组织学上可识别的肿瘤而融合。肿瘤沿狭窄针道扩展或FNA后囊肿内容物溢出不构成ENE。结论:本文提供了一致的建议,包括ENE的定义、淋巴结的宏观和组织学检查以及处理挑战性病例的实用指南。
{"title":"International Consensus Recommendations of Diagnostic Criteria and Terminologies for Extranodal Extension in Head and Neck Squamous Cell Carcinoma: An HN CLEAR Initiative (Update 1).","authors":"Ruta Gupta, Timothy Fielder, Munita Bal, Simion I Chiosea, Jane E Dahlstrom, Aanchal Kakkar, Katalin Kiss, Jan Laco, Neha Mittal, Sunil Pasricha, Spinder Samra, Nina Zidar, Martin Bullock, Rebecca Chernock, William Faquin, Shao Hui Huang, Jean Yang, Sun Och Yoon","doi":"10.1007/s12105-025-01753-7","DOIUrl":"10.1007/s12105-025-01753-7","url":null,"abstract":"<p><strong>Purpose: </strong>Extranodal extension (ENE) increases the risk of recurrence and death in head and neck squamous cell carcinoma (HNSCC) patients and is an indication for treatment escalation. Histopathology forms the mainstay of diagnosing ENE. There is substantial variation in the diagnosis of ENE and related terminology. Harmonising the diagnostic criteria for ENE was identified as a priority by the Head and Neck Consensus Language for Ease of Reproducibility (HN CLEAR) Steering Committee and its global stakeholders.</p><p><strong>Methods: </strong>An international working group including 16 head and neck pathologists from eight countries across five continents evaluated whole slide images of haematoxylin and eosin-stained sections depicting potential diagnostic problems through nine virtual meetings to develop consensus guidelines.</p><p><strong>Results: </strong>ENE should be diagnosed only when viable carcinoma extends through the primary lymph node (LN) capsule and directly interacts with the extranodal host environment with or without desmoplastic stromal response. Identifying the original LN capsule and reconstruction of its contour can assist in the detection and assessment of ENE. The term matting is recommended for confluence of two or more nodes due to histologically identifiable tumour extending from one LN to another. Matting constitutes major form of ENE. On the other hand, the terms fusion/adhesion/confluence/conglomeration and other synonyms of adhesion should be limited to confluence due to fibrosis or inflammation without histologically identifiable tumour between involved lymph nodes. Tumour extension along narrow needle tracks or spillage of cyst contents following an FNA do not constitute ENE.</p><p><strong>Conclusions: </strong>The consensus recommendations encompassing the definition of ENE, macroscopic and histologic examination of lymph nodes (LN) and practical guidelines for handling challenging cases are provided.</p>","PeriodicalId":47972,"journal":{"name":"Head & Neck Pathology","volume":"19 1","pages":"20"},"PeriodicalIF":4.1,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11805726/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143366561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic Criteria for Oral Epithelial Dysplasia: Predicting Malignant Transformation. 口腔上皮发育不良的诊断标准:预测恶性转化。
IF 4.1 Q2 PATHOLOGY Pub Date : 2025-02-07 DOI: 10.1007/s12105-025-01754-6
Amanda Zimmer Rodrigues, Natalia Koerich Laureano, Bruna Jalfim Maraschin, Alessandra Dutra da Silva, Viviane Palmeira da Silva, Pantelis Varvaki Rados, Fernanda Visioli

Purpose: In 2022, the World Health Organization (WHO) proposed new criteria for the diagnosis of oral epithelial dysplasia (OED), however their association with patient's outcome is still unknown. This study compared the different classification systems of OED and evaluate their efficacy in predicting malignant transformation.

Methods: A total of 195 slides of leukoplakia and erythroplakia were graded according to the WHO 2017, 2022, and the Binary System classification, and were correlated with the lesion's evolution.

Results: A progressive increase in malignant transformation according to the severity of OED, with both the WHO and the Binary classification systems was detected. Among individual criteria, changes in cell morphology were independently associated with an increased risk of malignant transformation (HR = 2.8, 95%CI 1.1-7.5, p = 0.032). Considering the new set of OED criteria published in 2022, it was detected that a new cutoff of 4 architectural alterations and 6 cytological alterations predicts better malignant transformation.

Conclusion: Malignant transformation was equally predicted by the OED classification systems. Due to the increased number of architectural and cytological features in WHO 2022, a new cutoff for classifying OED from low to high-grade considering 4 architectural and 6 cytological alterations is proposed. The findings allow a more accurate assessment of malignant transformation risk in OED.

目的:2022年,世界卫生组织(WHO)提出了口腔上皮发育不良(OED)的新诊断标准,但其与患者预后的关系尚不清楚。本研究比较了不同的OED分类系统,并评价其在预测恶性转化方面的功效。方法:根据WHO 2017、2022和二元系统分级,对195张白斑和红斑切片进行分级,并与病变进展进行相关性分析。结果:根据OED的严重程度,检测到WHO和二元分类系统的恶性转化逐渐增加。在个体标准中,细胞形态的改变与恶性转化的风险增加独立相关(HR = 2.8, 95%CI 1.1-7.5, p = 0.032)。考虑到2022年发布的OED新标准,我们发现,4个建筑改变和6个细胞学改变的新界限预示着更好的恶性转化。结论:OED分类系统对恶性转化的预测效果相同。由于世卫组织2022年的建筑和细胞学特征数量增加,考虑到4个建筑和6个细胞学改变,提出了从低到高级别的OED分类的新截止点。研究结果允许对牛津英语词典的恶性转化风险进行更准确的评估。
{"title":"Diagnostic Criteria for Oral Epithelial Dysplasia: Predicting Malignant Transformation.","authors":"Amanda Zimmer Rodrigues, Natalia Koerich Laureano, Bruna Jalfim Maraschin, Alessandra Dutra da Silva, Viviane Palmeira da Silva, Pantelis Varvaki Rados, Fernanda Visioli","doi":"10.1007/s12105-025-01754-6","DOIUrl":"10.1007/s12105-025-01754-6","url":null,"abstract":"<p><strong>Purpose: </strong>In 2022, the World Health Organization (WHO) proposed new criteria for the diagnosis of oral epithelial dysplasia (OED), however their association with patient's outcome is still unknown. This study compared the different classification systems of OED and evaluate their efficacy in predicting malignant transformation.</p><p><strong>Methods: </strong>A total of 195 slides of leukoplakia and erythroplakia were graded according to the WHO 2017, 2022, and the Binary System classification, and were correlated with the lesion's evolution.</p><p><strong>Results: </strong>A progressive increase in malignant transformation according to the severity of OED, with both the WHO and the Binary classification systems was detected. Among individual criteria, changes in cell morphology were independently associated with an increased risk of malignant transformation (HR = 2.8, 95%CI 1.1-7.5, p = 0.032). Considering the new set of OED criteria published in 2022, it was detected that a new cutoff of 4 architectural alterations and 6 cytological alterations predicts better malignant transformation.</p><p><strong>Conclusion: </strong>Malignant transformation was equally predicted by the OED classification systems. Due to the increased number of architectural and cytological features in WHO 2022, a new cutoff for classifying OED from low to high-grade considering 4 architectural and 6 cytological alterations is proposed. The findings allow a more accurate assessment of malignant transformation risk in OED.</p>","PeriodicalId":47972,"journal":{"name":"Head & Neck Pathology","volume":"19 1","pages":"21"},"PeriodicalIF":4.1,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11806176/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143366560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Utility of Autophagy Marker Beclin1 in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. 自噬标志物Beclin1在口腔鳞状细胞癌中的预后价值:系统回顾和荟萃分析。
IF 4.1 Q2 PATHOLOGY Pub Date : 2025-02-05 DOI: 10.1007/s12105-025-01755-5
Tajindra Singh Saluja, Rashmi Hosalkar

Background: Autophagy is involved in several critical cellular processes regulating cell survival and death. Past research suggests that it may either act as a tumor suppressor or promote tumor progression. The purpose of this systematic review and meta-analysis was to evaluate the clinical and prognostic utility of a significant autophagy related protein-Beclin1, in oral squamous cell carcinoma (OSCC).

Methods: Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines were followed. Relevant literature was retrieved from PubMed, ScienceDirect and Google Scholar database. After removal of duplicates quality of the studies was assessed using Newcastle-Ottawa Scale. Heterogeneity was assessed using I2 index. Random effect model was used if I2 was more than 50% else fixed effect model was selected. Meta-analysis was carried out using Review Manager (RevMan; Version 5.4).

Results: Five studies with 494 cases were included in this meta-analysis. Beclin1 expression in OSCC was not significantly associated (p > 0.05) with gender, age, tumor size, lymph node metastasis, histological differentiation and overall survival. Nevertheless, a trend for low Beclin1 expression favoring tumor progression was observed. Sensitivity analysis revealed significant nodal positivity related to low Beclin1 expression.

Conclusion: This study provided an overview of Beclin1 expression in OSCC and highlighted additional evaluations while its use as a prognostic marker. It is suggested that future studies should assess both nuclear as well as cytoplasmic expression of Beclin1 and report intra- and inter-tumor variations in its expression relating to clinicopathological parameters.

背景:自噬参与调节细胞生存和死亡的几个关键细胞过程。过去的研究表明,它可能起到肿瘤抑制或促进肿瘤进展的作用。本系统综述和荟萃分析的目的是评估一种重要的自噬相关蛋白beclin1在口腔鳞状细胞癌(OSCC)中的临床和预后效用。方法:遵循系统评价和荟萃分析(PRISMA)指南的首选报告项目。相关文献检索自PubMed、ScienceDirect和谷歌Scholar数据库。去除重复项后,使用纽卡斯尔-渥太华量表评估研究的质量。采用I2指数评价异质性。I2大于50%采用随机效应模型,否则采用固定效应模型。meta分析采用Review Manager (RevMan;版本5.4)。结果:本荟萃分析纳入了5项研究,共494例。Beclin1在OSCC中的表达与性别、年龄、肿瘤大小、淋巴结转移、组织学分化及总生存期无显著相关性(p < 0.05)。然而,观察到低Beclin1表达倾向于肿瘤进展。敏感性分析显示淋巴结阳性与Beclin1低表达相关。结论:本研究概述了Beclin1在OSCC中的表达,并强调了其作为预后标志物的其他评估。建议未来的研究应评估Beclin1的细胞核和细胞质表达,并报告其与临床病理参数相关的肿瘤内和肿瘤间表达变化。
{"title":"Prognostic Utility of Autophagy Marker Beclin1 in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.","authors":"Tajindra Singh Saluja, Rashmi Hosalkar","doi":"10.1007/s12105-025-01755-5","DOIUrl":"10.1007/s12105-025-01755-5","url":null,"abstract":"<p><strong>Background: </strong>Autophagy is involved in several critical cellular processes regulating cell survival and death. Past research suggests that it may either act as a tumor suppressor or promote tumor progression. The purpose of this systematic review and meta-analysis was to evaluate the clinical and prognostic utility of a significant autophagy related protein-Beclin1, in oral squamous cell carcinoma (OSCC).</p><p><strong>Methods: </strong>Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines were followed. Relevant literature was retrieved from PubMed, ScienceDirect and Google Scholar database. After removal of duplicates quality of the studies was assessed using Newcastle-Ottawa Scale. Heterogeneity was assessed using I<sup>2</sup> index. Random effect model was used if I<sup>2</sup> was more than 50% else fixed effect model was selected. Meta-analysis was carried out using Review Manager (RevMan; Version 5.4).</p><p><strong>Results: </strong>Five studies with 494 cases were included in this meta-analysis. Beclin1 expression in OSCC was not significantly associated (p > 0.05) with gender, age, tumor size, lymph node metastasis, histological differentiation and overall survival. Nevertheless, a trend for low Beclin1 expression favoring tumor progression was observed. Sensitivity analysis revealed significant nodal positivity related to low Beclin1 expression.</p><p><strong>Conclusion: </strong>This study provided an overview of Beclin1 expression in OSCC and highlighted additional evaluations while its use as a prognostic marker. It is suggested that future studies should assess both nuclear as well as cytoplasmic expression of Beclin1 and report intra- and inter-tumor variations in its expression relating to clinicopathological parameters.</p>","PeriodicalId":47972,"journal":{"name":"Head & Neck Pathology","volume":"19 1","pages":"17"},"PeriodicalIF":4.1,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11799460/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143190946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ameloblastic Fibro-Odontoma with an FGFR1 Mutation: A Case Report. 伴有FGFR1突变的成釉纤维齿瘤:1例报告。
IF 4.1 Q2 PATHOLOGY Pub Date : 2025-02-05 DOI: 10.1007/s12105-025-01758-2
Oumaima Aouam, Nard G Janssen, Wendy W J de Leng, Gerben E Breimer

Purpose: Ameloblastic fibro-odontoma (AFO) is a rare benign mixed odontogenic tumor that, after being classified for years as a distinct entity, was redefined as a "developing odontoma" in the 2017 World Health Organization classification. This article presents a unique case of an AFO with an FGFR1 mutation.

Methods: We present a case of an 8-year-old child with a slowly progressive swelling in the lower left mandible. Next-generation sequencing (TSO500 panel) was performed.

Results: Panoramic radiography revealed an odontogenic tumor; therefore, a transoral enucleation was performed. Pathological microscopic examination confirmed the diagnosis of AFO, and next-generation sequencing detected an FGFR1 mutation.

Conclusion: The presence of an FGFR1 mutation in an AFO may suggest a closer biological relationship between ameloblastic fibroma and AFO, potentially distinguishing it from odontomas. Further research, including genetic studies, is needed to enhance our understanding and refine the classification of these tumors.

目的:成釉纤维-牙瘤(AFO)是一种罕见的良性混合牙源性肿瘤,在被分类为一个独立的实体多年后,在2017年世界卫生组织分类中被重新定义为“发展中的牙瘤”。这篇文章提出了一个独特的AFO与FGFR1突变的情况。方法:我们提出一个病例8岁的儿童与缓慢进行性肿胀在左下下颌骨。进行下一代测序(TSO500面板)。结果:全景x线片显示牙源性肿瘤;因此,我们进行了经口去核手术。病理显微镜检查证实了AFO的诊断,下一代测序检测到FGFR1突变。结论:AFO中FGFR1突变的存在可能表明成釉纤维瘤和AFO之间存在更密切的生物学关系,可能将其与牙瘤区分开来。需要进一步的研究,包括遗传学研究,来提高我们对这些肿瘤的理解和完善分类。
{"title":"Ameloblastic Fibro-Odontoma with an FGFR1 Mutation: A Case Report.","authors":"Oumaima Aouam, Nard G Janssen, Wendy W J de Leng, Gerben E Breimer","doi":"10.1007/s12105-025-01758-2","DOIUrl":"10.1007/s12105-025-01758-2","url":null,"abstract":"<p><strong>Purpose: </strong>Ameloblastic fibro-odontoma (AFO) is a rare benign mixed odontogenic tumor that, after being classified for years as a distinct entity, was redefined as a \"developing odontoma\" in the 2017 World Health Organization classification. This article presents a unique case of an AFO with an FGFR1 mutation.</p><p><strong>Methods: </strong>We present a case of an 8-year-old child with a slowly progressive swelling in the lower left mandible. Next-generation sequencing (TSO500 panel) was performed.</p><p><strong>Results: </strong>Panoramic radiography revealed an odontogenic tumor; therefore, a transoral enucleation was performed. Pathological microscopic examination confirmed the diagnosis of AFO, and next-generation sequencing detected an FGFR1 mutation.</p><p><strong>Conclusion: </strong>The presence of an FGFR1 mutation in an AFO may suggest a closer biological relationship between ameloblastic fibroma and AFO, potentially distinguishing it from odontomas. Further research, including genetic studies, is needed to enhance our understanding and refine the classification of these tumors.</p>","PeriodicalId":47972,"journal":{"name":"Head & Neck Pathology","volume":"19 1","pages":"19"},"PeriodicalIF":4.1,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11799477/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143190919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intraoral Lymphomatoid Papulosis Type D Showing Scarce/Absent CD30 Expression in A Pediatric Patient: Case Report and Literature Review. 一名小儿患者口腔内淋巴瘤样丘疹病 D 型显示稀少/缺失 CD30 表达:病例报告与文献综述
IF 4.1 Q2 PATHOLOGY Pub Date : 2025-02-05 DOI: 10.1007/s12105-024-01749-9
Mariana Paravani Palaçon, Marcelo Borges Marques, Débora Fernandes Mendes Silveira, Karina Helen Martins, Heitor Albergoni Silveira, Valfrido Antonio Pereira-Filho, Andreia Bufalino, Fernando Chahud, Jorge Esquiche León

Purpose: Approximately 10% of all lymphomatoid papulosis (LyP) cases affect pediatric patients. Pediatric LyP is clinically similar to adult LyP, frequently with cutaneous involvement, whereas the affectation of mucosal surface is rare. The LyP clinicopathological spectrum includes type A, B, C, D, E, and LyP with DUSP22/IRF4 rearrangement, with LyP type D representing < 5% of all LyP cases.

Methods: We have previously reported 2 cases of exclusively intraoral LyP type C and E. To date, about 50 cases of LyP type D have been reported; of them, 8 cases, all but one with exclusive skin involvement, corresponded to pediatric patients. Rare LyP type C cases can lack CD30 expression, creating diagnostic difficulties with lymphoma.

Results: Here, we report an extremely rare case of intraoral LyP type D with scarce/absent CD30 expression affecting a 12-year-old white Brazilian boy.

Conclusions: To our best knowledge, this is the first pediatric case of LyP type D with exclusive intraoral involvement.

目的:大约10%的淋巴瘤样丘疹病(LyP)病例影响儿科患者。儿童LyP的临床表现与成人LyP相似,常伴有皮肤受累,而粘膜表面的影响是罕见的。LyP临床病理谱包括A型、B型、C型、D型、E型和伴有DUSP22/IRF4重排的LyP,其中以D型LyP为代表。方法:我们先前报道了2例完全口服内的C型和E型LyP,迄今已报道的D型LyP约50例;其中8例均为小儿患者,除1例外均为皮肤受累。罕见的LyP C型病例缺乏CD30表达,给淋巴瘤的诊断带来困难。结果:在这里,我们报告了一例极其罕见的口腔内LyP D型伴CD30表达缺失的病例,患者为一名12岁的巴西白人男孩。结论:据我们所知,这是第一例单纯口腔内受累的儿童LyP D型病例。
{"title":"Intraoral Lymphomatoid Papulosis Type D Showing Scarce/Absent CD30 Expression in A Pediatric Patient: Case Report and Literature Review.","authors":"Mariana Paravani Palaçon, Marcelo Borges Marques, Débora Fernandes Mendes Silveira, Karina Helen Martins, Heitor Albergoni Silveira, Valfrido Antonio Pereira-Filho, Andreia Bufalino, Fernando Chahud, Jorge Esquiche León","doi":"10.1007/s12105-024-01749-9","DOIUrl":"10.1007/s12105-024-01749-9","url":null,"abstract":"<p><strong>Purpose: </strong>Approximately 10% of all lymphomatoid papulosis (LyP) cases affect pediatric patients. Pediatric LyP is clinically similar to adult LyP, frequently with cutaneous involvement, whereas the affectation of mucosal surface is rare. The LyP clinicopathological spectrum includes type A, B, C, D, E, and LyP with DUSP22/IRF4 rearrangement, with LyP type D representing < 5% of all LyP cases.</p><p><strong>Methods: </strong>We have previously reported 2 cases of exclusively intraoral LyP type C and E. To date, about 50 cases of LyP type D have been reported; of them, 8 cases, all but one with exclusive skin involvement, corresponded to pediatric patients. Rare LyP type C cases can lack CD30 expression, creating diagnostic difficulties with lymphoma.</p><p><strong>Results: </strong>Here, we report an extremely rare case of intraoral LyP type D with scarce/absent CD30 expression affecting a 12-year-old white Brazilian boy.</p><p><strong>Conclusions: </strong>To our best knowledge, this is the first pediatric case of LyP type D with exclusive intraoral involvement.</p>","PeriodicalId":47972,"journal":{"name":"Head & Neck Pathology","volume":"19 1","pages":"14"},"PeriodicalIF":4.1,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11799464/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143190924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
STAT3 Expression in Organ-Preserved Laryngeal Carcinomas: Correlation with Treatment Resistance and Conventional Parameters. STAT3在器官保存喉癌中的表达:与治疗耐药性和常规参数的相关性。
IF 4.1 Q2 PATHOLOGY Pub Date : 2025-02-05 DOI: 10.1007/s12105-024-01748-w
Esra Nur Bayır, Ünsal Han, Ömer Bayır, Seda Işık, Güleser Saylam, Doğan Yazılıtaş, Mustafa Cengiz, Mehmet Hakan Korkmaz

Background: One of the major challenges in the treatment of laryngeal squamous cell carcinoma (LSCC) with organ-preserving therapies is the emergence of treatment resistance. The JAK/STAT pathway has been increasingly implicated in this resistance, particularly through the overexpression or persistent activation of STAT3. Increased STAT3 expression is thought to be associated with resistance to radiotherapy and/or chemotherapy, and STAT3 inhibitors have been proposed as potential targeted treatments.

Objectives: The primary objective of this study is to investigate the relationship between STAT3 expression and treatment resistance in patients with LSCC undergoing organ-preserving therapy and to evaluate the association between STAT3 expression and clinical/histopathologic prognostic parameters. A secondary objective is to evaluate STAT3 expression in diagnostic biopsies and laryngectomy specimens from treatment-resistant patients to investigate the potential predictability of treatment resistance from initial biopsy specimens.

Methodology: The study included 123 patients diagnosed with LSCC between 2008 and 2022, all of whom received nonsurgical treatment. Patients were divided into two groups based on their response to treatment: treatment-sensitive patient group (TSPG) and treatment-resistant patient group (TRPG). Immunohistochemical staining for p-STAT3 was performed on a diagnostic biopsy for each TSPG patient and on both pre- and post-treatment biopsies for each TRPG patient. STAT3 expression levels were scored and their association with treatment resistance, clinical and pathological parameters was analysed.

Results: No statistically significant difference in p-STAT3 expression was found between the two groups. TSPG patients were significantly older at diagnosis (p = 0.038), and tumor location differed between groups (p = 0.001). No significant differences in histopathologic or clinical prognostic parameters were observed between patients with high and low STAT3 expression. In addition, no significant difference in STAT3 staining was found between diagnostic biopsies and laryngectomy specimens in TRPG patients.

Conclusion: STAT3 expression was not associated with treatment resistance in LSCC, and its expression level did not correlate with prognostic parameters or survival outcomes. Therefore, STAT3 does not appear to be a useful biomarker for predicting treatment resistance or prognosis in LSCC.

背景:器官保留疗法治疗喉鳞状细胞癌(LSCC)的主要挑战之一是治疗耐药性的出现。JAK/STAT通路越来越多地参与这种耐药性,特别是通过STAT3的过表达或持续激活。STAT3表达的增加被认为与放疗和/或化疗的耐药性有关,STAT3抑制剂被认为是潜在的靶向治疗。目的:本研究的主要目的是研究接受器官保留治疗的LSCC患者中STAT3表达与治疗耐药之间的关系,并评估STAT3表达与临床/组织病理学预后参数之间的关系。次要目的是评估来自治疗耐药患者的诊断活检和喉切除术标本中的STAT3表达,以研究初始活检标本对治疗耐药的潜在可预测性。方法:该研究纳入了2008年至2022年间诊断为LSCC的123例患者,所有患者均接受了非手术治疗。根据患者对治疗的反应将患者分为两组:治疗敏感组(TSPG)和治疗抵抗组(TRPG)。对每个TSPG患者的诊断活检以及每个TRPG患者的治疗前和治疗后活检进行p-STAT3的免疫组织化学染色。对STAT3表达水平进行评分,并分析其与耐药、临床及病理参数的关系。结果:两组间p-STAT3表达差异无统计学意义。TSPG患者在诊断时明显年龄较大(p = 0.038),两组间肿瘤位置差异较大(p = 0.001)。STAT3高表达和低表达患者的组织病理学和临床预后参数无显著差异。此外,在TRPG患者的诊断活检和喉切除术标本中,STAT3染色无显著差异。结论:STAT3表达与LSCC治疗耐药无关,其表达水平与预后参数或生存结果无关。因此,STAT3似乎不是预测LSCC治疗耐药或预后的有用生物标志物。
{"title":"STAT3 Expression in Organ-Preserved Laryngeal Carcinomas: Correlation with Treatment Resistance and Conventional Parameters.","authors":"Esra Nur Bayır, Ünsal Han, Ömer Bayır, Seda Işık, Güleser Saylam, Doğan Yazılıtaş, Mustafa Cengiz, Mehmet Hakan Korkmaz","doi":"10.1007/s12105-024-01748-w","DOIUrl":"10.1007/s12105-024-01748-w","url":null,"abstract":"<p><strong>Background: </strong>One of the major challenges in the treatment of laryngeal squamous cell carcinoma (LSCC) with organ-preserving therapies is the emergence of treatment resistance. The JAK/STAT pathway has been increasingly implicated in this resistance, particularly through the overexpression or persistent activation of STAT3. Increased STAT3 expression is thought to be associated with resistance to radiotherapy and/or chemotherapy, and STAT3 inhibitors have been proposed as potential targeted treatments.</p><p><strong>Objectives: </strong>The primary objective of this study is to investigate the relationship between STAT3 expression and treatment resistance in patients with LSCC undergoing organ-preserving therapy and to evaluate the association between STAT3 expression and clinical/histopathologic prognostic parameters. A secondary objective is to evaluate STAT3 expression in diagnostic biopsies and laryngectomy specimens from treatment-resistant patients to investigate the potential predictability of treatment resistance from initial biopsy specimens.</p><p><strong>Methodology: </strong>The study included 123 patients diagnosed with LSCC between 2008 and 2022, all of whom received nonsurgical treatment. Patients were divided into two groups based on their response to treatment: treatment-sensitive patient group (TSPG) and treatment-resistant patient group (TRPG). Immunohistochemical staining for p-STAT3 was performed on a diagnostic biopsy for each TSPG patient and on both pre- and post-treatment biopsies for each TRPG patient. STAT3 expression levels were scored and their association with treatment resistance, clinical and pathological parameters was analysed.</p><p><strong>Results: </strong>No statistically significant difference in p-STAT3 expression was found between the two groups. TSPG patients were significantly older at diagnosis (p = 0.038), and tumor location differed between groups (p = 0.001). No significant differences in histopathologic or clinical prognostic parameters were observed between patients with high and low STAT3 expression. In addition, no significant difference in STAT3 staining was found between diagnostic biopsies and laryngectomy specimens in TRPG patients.</p><p><strong>Conclusion: </strong>STAT3 expression was not associated with treatment resistance in LSCC, and its expression level did not correlate with prognostic parameters or survival outcomes. Therefore, STAT3 does not appear to be a useful biomarker for predicting treatment resistance or prognosis in LSCC.</p>","PeriodicalId":47972,"journal":{"name":"Head & Neck Pathology","volume":"19 1","pages":"16"},"PeriodicalIF":4.1,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11799471/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143190949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multifocal Necrotizing Sialometaplasia in the Tongue Surgical Specimen: An Immunohistochemical Study. 舌头手术标本中的多灶性坏死性鞘膜积液:免疫组化研究。
IF 4.1 Q2 PATHOLOGY Pub Date : 2025-02-05 DOI: 10.1007/s12105-025-01756-4
Marcelo Borges Marques, Gabriela Esperanza Maradiaga Posantes, Luana Stefanie Silvino Gonçalves, Anderson Tangerino Ferreira da Silva, Heitor Albergoni Silveira, Fernando Chahud, Jorge Esquiche León

Background: Necrotizing sialometaplasia (NSM) is a rare self-limiting inflammatory lesion, with most cases affecting the minor salivary glands, especially those located in the palate (70%). To date, about 261 cases of NSM have been reported. Of them, 7 cases affected the tongue; 37 cases occurred after surgery; and 17 cases showed association with neoplasms.

Methods: A 50-year-old male patient was diagnosed with squamous cell carcinoma (SCC) of the tongue. After surgical excision, the tumor diagnosis was well-differentiated SCC with a close surgical margin. Re-excision of the margin was indicated.

Results: Microscopically, the surgical margin showed neither residual SCC nor epithelial dysplasia. However, it was possible to observe 7 foci containing typical areas of NSM distributed throughout the surgical specimen, which, by immunohistochemistry, revealed a glandular nature with presence of myoepithelial cells.

Conclusion: We present here an unusual multifocal NSM affecting the tongue at the site of a prior resection for SCC with close margins, which, to the best of our knowledge, has not been reported to date.

背景:坏死性唾液化生(NSM)是一种罕见的自限性炎症性病变,大多数病例影响小涎腺,尤其是位于腭部的涎腺(70%)。迄今为止,已报告约261例NSM病例。其中舌部病变7例;术后37例;伴有肿瘤17例。方法:一位50岁男性患者被诊断为舌鳞癌(SCC)。手术切除后,肿瘤诊断为高分化鳞状细胞癌,手术切缘紧密。建议再次切除切缘。结果:镜下,手术边缘未见鳞状细胞癌残留,也未见上皮异常增生。然而,在整个手术标本中可以观察到7个包含典型NSM区域的病灶,通过免疫组化,显示了肌上皮细胞存在的腺体性质。结论:我们在这里提出了一种不寻常的多灶性NSM,影响舌头在先前切除的鳞状细胞癌与近缘,这是据我们所知,迄今为止尚未报道。
{"title":"Multifocal Necrotizing Sialometaplasia in the Tongue Surgical Specimen: An Immunohistochemical Study.","authors":"Marcelo Borges Marques, Gabriela Esperanza Maradiaga Posantes, Luana Stefanie Silvino Gonçalves, Anderson Tangerino Ferreira da Silva, Heitor Albergoni Silveira, Fernando Chahud, Jorge Esquiche León","doi":"10.1007/s12105-025-01756-4","DOIUrl":"10.1007/s12105-025-01756-4","url":null,"abstract":"<p><strong>Background: </strong>Necrotizing sialometaplasia (NSM) is a rare self-limiting inflammatory lesion, with most cases affecting the minor salivary glands, especially those located in the palate (70%). To date, about 261 cases of NSM have been reported. Of them, 7 cases affected the tongue; 37 cases occurred after surgery; and 17 cases showed association with neoplasms.</p><p><strong>Methods: </strong>A 50-year-old male patient was diagnosed with squamous cell carcinoma (SCC) of the tongue. After surgical excision, the tumor diagnosis was well-differentiated SCC with a close surgical margin. Re-excision of the margin was indicated.</p><p><strong>Results: </strong>Microscopically, the surgical margin showed neither residual SCC nor epithelial dysplasia. However, it was possible to observe 7 foci containing typical areas of NSM distributed throughout the surgical specimen, which, by immunohistochemistry, revealed a glandular nature with presence of myoepithelial cells.</p><p><strong>Conclusion: </strong>We present here an unusual multifocal NSM affecting the tongue at the site of a prior resection for SCC with close margins, which, to the best of our knowledge, has not been reported to date.</p>","PeriodicalId":47972,"journal":{"name":"Head & Neck Pathology","volume":"19 1","pages":"18"},"PeriodicalIF":4.1,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11799453/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143190929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Head & Neck Pathology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1